Get In Touch
Xeraya Capital Sdn Bhd
26.03–26.08, G Tower
#199 Jalan Tun Razak, KL
+603 2381 8700
Submit a Proposal


Transcatheter annuloplasty system for tricuspid and mitral regurgitation

Mitralign Inc. is the valve repair company with the only direct transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. It has developed an innovative therapy for the reduction of functional mitral regurgitation (FMR), a life-threatening cardiac condition affecting four million people in the US alone. Its unique system provides a new solution for interventional cardiologists and their patients.

  • Founded


  • Partnered


  • Divested

    2019 (Edwards Life Sciences)

Let's talk

Are you the next big thing?

We’re a team of VC/PE who are excited about innovative ideas in life sciences. Submit your proposal to us!